Anthraquinone Derivatives as an Immune Booster and their Therapeutic Option Against COVID-19
Crossref DOI link: https://doi.org/10.1007/s13659-020-00260-2
Published Online: 2020-08-08
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khanal, Pukar http://orcid.org/0000-0002-8187-2120
Patil, B. M.
Chand, Jagdish
Naaz, Yasmin
Text and Data Mining valid from 2020-08-08
Version of Record valid from 2020-08-08
Article History
Received: 23 June 2020
Accepted: 1 August 2020
First Online: 8 August 2020
Compliance with Ethical Standards
:
: There is no conflict of interest.
: This manuscript doesn’t include any animal or human studies.